Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetards Regulatory News (PEG)

Share Price Information for Petards (PEG)

Share Price is delayed by 15 minutes
Get Live Data
9.25    -0.25 (-2.63%)
Bid:
9.00
Ask:
9.50
Spread: 0.50 (5.556%)
Market Cap: £5.62m
PEG Live PriceLast checked at - London Stock Exchange

Intraday Petards Share Chart

Trading Update

5 Feb 2026 07:00

RNS Number : 7668R
Petards Group PLC
05 February 2026
Β 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Β 

Β 

5 February 2026

Β 

Petards Group plc

("Petards" or the "Group")

Trading update

Petards Group plc (AIM: PEG),Β the AIM quoted developer of advanced security, communication and surveillance systems, is pleased to provide a trading update for the year ended 31 December 2025.

The improvement in the Group's financial performance seen in the first half-year was sustained over the remainder of the year, with the year closing with an improved order book.

Adjusted EBITDA is expected to be in line with current market expectations and the Group expects to report (all figures are unaudited):

Β· Group revenues up 24% year-on-year of circa Β£14.9 million (2024: Β£12.0 million)

Β 

Β· Adjusted EBITDAΒΉ of circa Β£1.0 million (2024: Β£0.4 million)

Β 

Β· Total net debtΒ² as at 31 December 2025 of Β£1.3 million (31 December 2024: Β£1.5 million)

The overall improvement in trading in 2025 reflected an upturn in trading at Petards Rail and Petards Defence, with both seeing increases in revenue and profitability over the prior year, and a profitable maiden full year's contribution from Affini.

While QRO secured some important framework contract wins during the year, delays in the placement of orders affected its trading in the second half-year resulting in lower revenues than those achieved in 2024. However, looking forward, revenue momentum is expected to recover on the back of those framework contracts, significant market interest in the newly launched Harrier Mini, and the conversion of overseas opportunities.

During the year, Petards generated cash of Β£1.4 million from operating activities (2024: Β£0.2 million), which after investing and financing cash flows, reduced total net debtΒ² to Β£1.3 million at 31 December 2025.

Order intake for the year for Petards Rail and in particular Petards Defence were at levels not seen for several years. Following contract awards from the MOD, RBSL and BAE Systems in the last two months of the year totalling Β£3.5 million, the Group's year end order book closed at Β£9.2 million (2024: Β£7.1 million) with around 85% scheduled for delivery in 2026.

Commenting on the current outlook, Raschid Abdullah, Chairman, said:

"Petards performed well in 2025 generating cash and increasing revenues, with improvements in gross profit margin and profitability, while increasing its order book to Β£9.2 million at the year end.

"The Group enters 2026 in a stronger position than it has in the past few years. While trading continues to be challenging with extended tendering processes, given the strength of the opening order book and its cover for 2026 revenues, the Group is well placed to deliver a continued improvement in its trading performance in the coming year."

Β 

Notes

Β 

ΒΉ Adjusted EBITDA is earnings before depreciation, amortisation, exceptional items, acquisition costs and share based payments

Β² Total net debt comprises cash and cash equivalents less interest bearing loans and borrowings

Β 

Contacts:

Petards Group plc

www.petards.com

Β 

Raschid Abdullah, Chairman

Mb: 07768 905 004

Β 

Β 

Β 

Β 

Zeus, Nomad and Joint Broker

Β 

Β 

Mike Coe / Darshan Patel (Investment Banking)

Tel: 020 3829 5000

Β 

Β 

Hybridan LLP, Joint Broker

www.hybridan.com

Claire Louise Noyce

Β 

Tel: 020 3764 2341

claire.noyce@hybridan.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUSVNRNWUURAR
Date   Source Headline
25th Jan 20247:00 amRNSTrading Update
4th Jan 20245:40 pmRNSHolding(s) in Company
3rd Jan 20245:21 pmRNSHolding(s) in Company
19th Dec 202310:55 amRNSDirectorate Change
14th Dec 202311:24 amRNSHolding(s) in Company
13th Dec 202311:43 amRNSHolding(s) in Company
7th Dec 20234:19 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSDirector Appointment
26th Sep 20237:00 amRNSHalf-year Report
14th Jun 20232:46 pmRNSResult of AGM
26th May 202312:26 pmRNSHolding(s) in Company
19th May 20233:08 pmRNSPosting of Annual Report and Notice of AGM
9th May 20237:00 amRNSFinal Results
1st Feb 20237:00 amRNSDirector Appointment
16th Jan 20232:56 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSHalf-year Report
8th Jun 20222:58 pmRNSResult of AGM
13th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
3rd Dec 20212:33 pmRNSHolding(s) in Company
30th Nov 20217:00 amRNSTransaction in Own Shares
29th Nov 20219:05 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
9th Nov 20212:56 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSHalf-year Report
22nd Jul 20212:40 pmRNSResult of AGM
1st Jul 20217:00 amRNSContract Award
28th Jun 20217:00 amRNSPosting of Accounts and Notice of AGM
24th Jun 20217:00 amRNSContract
28th May 20217:00 amRNSFinal Results
11th Feb 20217:00 amRNSTrading Update
8th Jan 20217:00 amRNSStmnt re Share Price Movement
9th Dec 20207:00 amRNSContract win
21st Oct 20207:00 amRNSContract win
14th Oct 20207:00 amRNSContract Win
24th Sep 20207:00 amRNSInterim Results
3rd Aug 20207:00 amRNSeyeCraft360 British Army trial success
24th Jul 20204:36 pmRNSHolding(s) in Company
23rd Jul 202011:32 amRNSResult of AGM
26th Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
18th Jun 20207:00 amRNSFinal Results
27th May 20209:54 amRNSServices Support Agreement
12th May 20207:00 amRNSServices Support Agreement
7th May 20207:00 amRNSAcquisition of New Product Line
28th Apr 202011:10 amRNSHolding(s) in Company
24th Apr 20207:00 amRNSCOVID-19 Update
4th Mar 20209:04 amRNSHolding(s) in Company
6th Feb 20204:23 pmRNSHolding(s) in Company
4th Feb 20207:00 amRNSTrading Update
13th Jan 20204:30 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.